We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$241M
AUM Growth
-$78.9M
Cap. Flow
-$81.4M
Cap. Flow %
-33.81%
Top 10 Hldgs %
74.61%
Holding
103
New
15
Increased
12
Reduced
10
Closed
54

Top Buys

Rank Stock Value
1
M icon
Macy's
M
+$24.4M
2
BAC icon
Bank of America
BAC
+$9.49M
3
VMC icon
Vulcan Materials
VMC
+$6.13M
4
CMG icon
Chipotle Mexican Grill
CMG
+$4.62M
5
CSX icon
CSX Corp
CSX
+$2.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$12.1M
2
TK icon
Teekay
TK
+$6.13M
3
CAT icon
Caterpillar
CAT
+$4.64M
4
PERY
Perry Ellis International Inc
PERY
+$2.33M
5
LITS
Lite Strategy Inc
LITS
+$2.06M

Sector Composition

Rank Sector Weight
1 Financials 17.07%
2 Consumer Discretionary 16.42%
3 Materials 10.57%
4 Technology 8.92%
5 Energy 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLNO
76
DELISTED
Soleno Therapeutics
SLNO
– –
-4,740
Closed -$288K
SWKS icon
77
PUT
Skyworks Solutions
SWKS
$9.54B
– –
-100,000
Closed -$7.47M
TK icon
78
Teekay
TK
$974M
– –
-763,597
Closed -$6.13M
TPST icon
79
Tempest Therapeutics
TPST
$14.9M
– –
-142
Closed -$637K
VSTM icon
80
Verastem
VSTM
$534M
– –
-28,704
Closed -$386K
XXII
81
22nd Century Group
XXII
$1.43M
– –
0
– -$1.18M
CSCI
82
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-568
Closed -$275K
IRD
83
Opus Genetics
IRD
$277M
– –
-11,270
Closed -$768K
SEEL
84
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
-2
Closed -$263K
ALPN
85
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-47,072
Closed -$422K
CTHR
86
DELISTED
Charles & Colvard Ltd
CTHR
– –
-18,474
Closed -$203K
LOV
87
DELISTED
Spark Networks SE American Depositary Shares
LOV
– –
-299,107
Closed -$251K
DRNA
88
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-99,658
Closed -$287K
SBBP
89
DELISTED
Strongbridge Biopharma plc.
SBBP
– –
-92,219
Closed -$221K
CHMA
90
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-205,380
Closed -$400K
NBRV
91
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
– –
-104
Closed -$155K
TUES
92
DELISTED
Tuesday Morning Corp
TUES
– –
-54,611
Closed -$295K
NVTR
93
DELISTED
Nuvectra Corporation Common Stock
NVTR
– –
-56,253
Closed -$283K
UQM
94
DELISTED
UQM Technologies, Inc.
UQM
– –
-565,204
Closed -$243K
ONCS
95
DELISTED
OncoSec Medical Incorporated
ONCS
– –
-1,033
Closed -$280K
CVRR
96
DELISTED
CVR Refining, LP
CVRR
– –
-50,000
Closed -$520K
ECYT
97
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-108,426
Closed -$276K
ANCB
98
DELISTED
Anchor Bancorp
ANCB
– –
-74,603
Closed -$2.03M
STLY
99
DELISTED
Stanley Furniture Co Inc
STLY
– –
-235,047
Closed -$212K
INVT
100
DELISTED
Inventergy Global, Inc.
INVT
– –
-205,149
Closed -$154K
1 2 3
4
5

Similar funds

RA
RPOA Advisors Plano, Texas $2.29B AUM 11.74% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
7WCP
71 West Capital Partners Boston, Massachusetts $2.27B AUM

Anson Funds Management's Q1 2017 Portfolio in Review

As of Q1 2017, Anson Funds Management held 103 positions worth $241M, down 25% from $320M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Anson Funds Management withdrew a net $81.4M in Q1 2017, closing 54 positions and reducing 10 holdings. Its most notable exit was Teekay, an estimated $6.13M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Materials.

Against the trend, Anson Funds Management opened a new position in Macy's worth $23.4M.

  • Anson Funds Management's largest Q1 2017 buy was Macy's: 791,000 shares worth $23.4M.
  • Anson Funds Management added most to Bank of America in Q1 2017, an estimated $9.49M increase.
  • Anson Funds Management's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $12.1M.
  • Anson Funds Management fully exited Teekay in Q1 2017, selling an estimated $6.13M.
  • Anson Funds Management's ten largest holdings make up 75% of its $241M portfolio in Q1 2017.
  • Anson Funds Management opened 15 new positions and closed 54 in Q1 2017.
  • Anson Funds Management's portfolio value fell 25% quarter-over-quarter to $241M.

Based on Anson Funds Management's 13F filing for Q1 2017, filed 15 May 2017.